Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_4

20%

Ph not_applicable

60%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 4Post-market surveillance

1(25.0%)

N/ANon-phased studies

3(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Other(3)

Detailed Status

unknown3

Completed2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 41 (25.0%)

N/A3 (75.0%)

Trials by Status

unknown360%

completed240%

Recent Activity

0 active trials

Showing 5 of 5

completednot_applicable

Extracorporeal Shock Wave Lithotripsy and Endotherapy for Pain in Chronic Pancreatitis

NCT03966781

unknownnot_applicable

Shock Wave Lithotripsy Versus Visual Cystolitholapaxy in The Management of Patients Presenting With Calcular Acute Urinary Retention: A Randomized Controlled Trial.

NCT02594631

Clinical Trials (5)

Showing 5 of 5 trials

NCT03966781Not Applicable

Extracorporeal Shock Wave Lithotripsy and Endotherapy for Pain in Chronic Pancreatitis

Completed

NCT05475782Not Applicable

Spyglass-guided Lithotripsy Versus ESWL for Pancreatic Duct Stones

Unknown

NCT02645058Not Applicable

RIRS Versus ESWL for the Treatment of Renal Stones

Completed

NCT03939325

ESWL on Disintegration of Renal Stones

Unknown

NCT02594631Phase 4

Shock Wave Lithotripsy Versus Visual Cystolitholapaxy in The Management of Patients Presenting With Calcular Acute Urinary Retention: A Randomized Controlled Trial.

Unknown

All 5 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 5